Hilton Toronto Airport Hotel | Toronto, ON, Canada
Wout Brusselaers, Deep 6 AI's CEO and co-founder, will present a plenary session on how artificial intelligence accelerates patient recruitment for clinical trials at the Canada Talks Pharma conference.
Canada Talks Pharma brings together professionals from pharma, biotech, medical device companies, CROs, SMOs, hospitals, Health Canada, the FDA and other government stakeholders to profile innovative ideas and new technologies in clinical research and participate in thoughtful discussions in research, policies, and international regulations.
The Intel ISEF, a program of Society for Science & the Public (the Society), is the world’s largest international pre-college science competition. In May 2018, more than 1,700 students representing 75 countries, regions, and territories will be in Pittsburgh to compete for more than $5 million in awards, scholarships, internships and prizes. These high school students are the top winners of regional, state and national science fairs from around the United States and the world.
Intel ISEF unites these top young scientific minds, showcasing their talents on an international stage, where doctoral level scientists review and judge their work.
Wout Brusselaers, CEO of Deep 6 AI, will speak at MAGI’s Clinical Research Conference - 2018 East as part of the (W858b) Master Class: Patient Recruiting & Retention workshop. Wout will discuss challenges associated with recruiting patients for clinical trials using EHR data.
MAGI is streamlining clinical research by standardizing best practices for clinical research operations, business and regulatory compliance. Its 10,000+ members represent clinical research sponsors, sites and CROs. MAGI's Clinical Research Conference - 2017 West offers 100+ sessions and workshops in six tracks - clinical operations and project management, site management, contracts, budgets & billing, regulatory compliance, and special topics - with 22+ contact hours available for CME, CNE, CLE, CCB and other credits.
DIA 2018 Global Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies.
Wout Brusselaers, Deep 6 AI's CEO and co-founder, will join the "Practical Applications of AI in Cancer" panel at the MedCity CONVERGE Conference.
MedCity CONVERGE is a two-day executive summit that gathers thought leaders from across all healthcare sectors to provide actionable insight on where oncology innovation is heading. Technology disruptors, payers, providers, life science companies, venture capitalists and more will gather to discuss how AI, big data, and precision medicine are changing the game in cancer.